# Skillsoft Corp.: financial statements, quarterly

SKIL · NYSE · CIK 1774675 · [Technology](/sectors/technology.md) · fiscal year ends Jan 31

Pages: [Overview](/companies/skil.md) · [Financials](/companies/skil/financials.md) · [Filings](/companies/skil/filings.md) · [Insiders](/companies/skil/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/skil/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2024 (2023-10-31) | Q4 FY2024 (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q4 FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [139](/filings/0001437749-24-037110.md) | [138 d](/filings/0001437749-26-011602.md) | [128](/filings/0001437749-25-019846.md) | [132](/filings/0001437749-25-028680.md) | [137](/filings/0001437749-25-037393.md) | [134 d](/filings/0001437749-26-011602.md) | [99.1](/filings/0001437749-26-019986.md) | [101](/filings/0001437749-26-029981.md) | [129](/filings/0001437749-25-037393.md) | [131 d](/filings/0001437749-26-011602.md) | [94.5](/filings/0001437749-26-019986.md) | [98.2](/filings/0001437749-26-029981.md) |
| Cost of revenue | $m | [36.4](/filings/0001437749-24-037110.md) | [38.5 d](/filings/0001437749-26-011602.md) | [34.5](/filings/0001437749-25-019846.md) | [32.5](/filings/0001437749-25-028680.md) | [34.3](/filings/0001437749-25-037393.md) | [33.6 d](/filings/0001437749-26-011602.md) | [16.5](/filings/0001437749-26-019986.md) | [15.9](/filings/0001437749-26-029981.md) | [35.3](/filings/0001437749-25-037393.md) | [34.2 d](/filings/0001437749-26-011602.md) | [15.9](/filings/0001437749-26-019986.md) | [15.1](/filings/0001437749-26-029981.md) |
| Research and development | $m | [16.1](/filings/0001437749-24-037110.md) | [17.0 d](/filings/0001437749-26-011602.md) | [15.5](/filings/0001437749-25-019846.md) | [15.0](/filings/0001437749-25-028680.md) | [14.9](/filings/0001437749-25-037393.md) | [15.3 d](/filings/0001437749-26-011602.md) | [13.3](/filings/0001437749-26-019986.md) | [13.6](/filings/0001437749-26-029981.md) | [13.8](/filings/0001437749-25-037393.md) | [13.4 d](/filings/0001437749-26-011602.md) | [13.1](/filings/0001437749-26-019986.md) | [11.6](/filings/0001437749-26-029981.md) |
| Operating income | $m | [(19.9)](/filings/0001437749-24-037110.md) | [(228) d](/filings/0001437749-26-011602.md) | [(23.8)](/filings/0001437749-25-019846.md) | [(19.3)](/filings/0001437749-25-028680.md) | [(9.2)](/filings/0001437749-25-037393.md) | [(17.3) d](/filings/0001437749-26-011602.md) | [(11.3)](/filings/0001437749-26-019986.md) | [(6.1)](/filings/0001437749-26-029981.md) | [(34.3)](/filings/0001437749-25-037393.md) | [(25.1) d](/filings/0001437749-26-011602.md) | [(8.3)](/filings/0001437749-26-019986.md) | [3.4](/filings/0001437749-26-029981.md) |
| Interest expense | $m | [16.5](/filings/0001437749-24-037110.md) | [16.7 d](/filings/0001437749-26-011602.md) | [16.3](/filings/0001437749-25-019846.md) | [16.4](/filings/0001437749-25-028680.md) | [15.8](/filings/0001437749-25-037393.md) | [15.0 d](/filings/0001437749-26-011602.md) | [14.4](/filings/0001437749-26-019986.md) | [15.0](/filings/0001437749-26-029981.md) | [14.8](/filings/0001437749-25-037393.md) | [14.4 d](/filings/0001437749-26-011602.md) | [13.7](/filings/0001437749-26-019986.md) | [14.2](/filings/0001437749-26-029981.md) |
| Income tax | $m | [(2.5)](/filings/0001437749-24-037110.md) | [(7.5) d](/filings/0001437749-26-011602.md) | [(1.6)](/filings/0001437749-25-019846.md) | [(2.1)](/filings/0001437749-25-028680.md) | [(1.9)](/filings/0001437749-25-037393.md) | [(0.2) d](/filings/0001437749-26-011602.md) | [(0.7)](/filings/0001437749-26-019986.md) | [(0.2)](/filings/0001437749-26-029981.md) | [(8.8)](/filings/0001437749-25-037393.md) | [(3.7) d](/filings/0001437749-26-011602.md) | [1.0](/filings/0001437749-26-019986.md) | [7.2](/filings/0001437749-26-029981.md) |
| Net income | $m | [(27.7)](/filings/0001437749-24-037110.md) | [(245) d](/filings/0001437749-26-011602.md) | [(27.6)](/filings/0001437749-25-037393.md) | [(39.6)](/filings/0001437749-25-037393.md) | [(23.6)](/filings/0001437749-25-037393.md) | [(31.1) d](/filings/0001437749-26-011602.md) | [(38.0)](/filings/0001437749-26-029981.md) | [(23.8)](/filings/0001437749-26-029981.md) | [(41.3)](/filings/0001437749-25-037393.md) | [(36.7) d](/filings/0001437749-26-011602.md) | [(43.1)](/filings/0001437749-26-029981.md) | [(42.4)](/filings/0001437749-26-029981.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | [(3.45)](/filings/0001437749-24-037110.md) | not reported | [(3.42)](/filings/0001437749-25-019846.md) | [(4.84)](/filings/0001437749-25-028680.md) | [(2.86)](/filings/0001437749-25-037393.md) | not reported | [(4.57)](/filings/0001437749-26-019986.md) | [(2.78)](/filings/0001437749-26-029981.md) | [(4.74)](/filings/0001437749-25-037393.md) | not reported | [(4.89)](/filings/0001437749-26-019986.md) | [(4.71)](/filings/0001437749-26-029981.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: not reported
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2024 (2023-10-31) | FY2024 (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [130](/filings/0001437749-23-033639.md) | [136](/filings/0001437749-25-011912.md) | [142](/filings/0001437749-25-019846.md) | [123](/filings/0001437749-25-028680.md) | [97.9](/filings/0001437749-25-037393.md) | [101](/filings/0001437749-26-011602.md) | [128](/filings/0001437749-25-019846.md) | [101](/filings/0001437749-25-028680.md) | [74.6](/filings/0001437749-25-037393.md) | [94.1](/filings/0001437749-26-029981.md) | [116](/filings/0001437749-26-019986.md) | [90.3](/filings/0001437749-26-029981.md) |
| Current assets | $m | [300](/filings/0001437749-23-033639.md) | [385](/filings/0001437749-25-011912.md) | [319](/filings/0001437749-24-019820.md) | [301](/filings/0001437749-24-028757.md) | [260](/filings/0001437749-24-037110.md) | [333](/filings/0001437749-26-011602.md) | [278](/filings/0001437749-25-019846.md) | [253](/filings/0001437749-25-028680.md) | [231](/filings/0001437749-25-037393.md) | [368](/filings/0001437749-26-029981.md) | [287](/filings/0001437749-26-019986.md) | [214](/filings/0001437749-26-029981.md) |
| Total assets | $m | [1,425](/filings/0001437749-23-033639.md) | [1,274](/filings/0001437749-25-011912.md) | [1,181](/filings/0001437749-24-019820.md) | [1,126](/filings/0001437749-24-028757.md) | [1,054](/filings/0001437749-24-037110.md) | [1,106](/filings/0001437749-26-011602.md) | [1,022](/filings/0001437749-25-019846.md) | [969](/filings/0001437749-25-028680.md) | [898](/filings/0001437749-25-037393.md) | [963](/filings/0001437749-26-029981.md) | [853](/filings/0001437749-26-019986.md) | [767](/filings/0001437749-26-029981.md) |
| Current liabilities | $m | [321](/filings/0001437749-23-033639.md) | [413](/filings/0001437749-25-011912.md) | [351](/filings/0001437749-24-019820.md) | [342](/filings/0001437749-24-028757.md) | [294](/filings/0001437749-24-037110.md) | [377](/filings/0001437749-26-011602.md) | [325](/filings/0001437749-25-019846.md) | [297](/filings/0001437749-25-028680.md) | [273](/filings/0001437749-25-037393.md) | [377](/filings/0001437749-26-029981.md) | [314](/filings/0001437749-26-019986.md) | [245](/filings/0001437749-26-029981.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Long-term debt | $m | [579](/filings/0001437749-23-033639.md) | [577](/filings/0001437749-25-011912.md) | [576](/filings/0001437749-24-019820.md) | [575](/filings/0001437749-24-028757.md) | [574](/filings/0001437749-24-037110.md) | [573](/filings/0001437749-26-011602.md) | [572](/filings/0001437749-25-019846.md) | [571](/filings/0001437749-25-028680.md) | [570](/filings/0001437749-25-037393.md) | [571](/filings/0001437749-26-029981.md) | [568](/filings/0001437749-26-019986.md) | [567](/filings/0001437749-26-029981.md) |
| Current portion of debt | $m | [6.4](/filings/0001437749-23-033639.md) | [6.4](/filings/0001437749-25-011912.md) | [6.4](/filings/0001437749-24-019820.md) | [6.4](/filings/0001437749-24-028757.md) | [6.4](/filings/0001437749-24-037110.md) | [6.4](/filings/0001437749-26-011602.md) | [6.4](/filings/0001437749-25-019846.md) | [6.4](/filings/0001437749-25-028680.md) | [6.4](/filings/0001437749-25-037393.md) | [6.4](/filings/0001437749-26-029981.md) | [6.4](/filings/0001437749-26-019986.md) | [6.4](/filings/0001437749-26-029981.md) |
| Short-term borrowings | $m | [40.5](/filings/0001437749-23-033639.md) | [45.0](/filings/0001437749-25-011912.md) | [42.4](/filings/0001437749-24-019820.md) | [40.4](/filings/0001437749-24-028757.md) | [10.0](/filings/0001437749-24-037110.md) | [1.0](/filings/0001437749-26-011602.md) | [1.0](/filings/0001437749-25-019846.md) | [1.0](/filings/0001437749-25-028680.md) | [1.0](/filings/0001437749-25-037393.md) | [1.0](/filings/0001437749-26-029981.md) | [1.0](/filings/0001437749-26-019986.md) | [1.0](/filings/0001437749-26-029981.md) |
| Shareholders' equity | $m | [440](/filings/0001437749-24-037110.md) | [206](/filings/0001437749-26-011602.md) | [182](/filings/0001437749-25-037393.md) | [141](/filings/0001437749-25-037393.md) | [120](/filings/0001437749-25-037393.md) | [93.8](/filings/0001437749-26-029981.md) | [62.6](/filings/0001437749-26-029981.md) | [42.5](/filings/0001437749-26-029981.md) | [4.0](/filings/0001437749-25-037393.md) | [(30.2)](/filings/0001437749-26-029981.md) | [(72.8)](/filings/0001437749-26-029981.md) | [(93.3)](/filings/0001437749-26-029981.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: not reported
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2024 (2023-10-31) | Q4 FY2024 (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q4 FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(10.7) d](/filings/0001437749-24-037110.md) | [11.5 d](/filings/0001437749-26-011602.md) | [14.9](/filings/0001437749-25-019846.md) | [(11.4) d](/filings/0001437749-25-028680.md) | [8.7 d](/filings/0001437749-25-037393.md) | [17.8 d](/filings/0001437749-26-011602.md) | [31.3](/filings/0001437749-26-019986.md) | [(17.8) d](/filings/0001437749-26-029981.md) | [(18.9) d](/filings/0001437749-25-037393.md) | [30.5 d](/filings/0001437749-26-011602.md) | [28.9](/filings/0001437749-26-019986.md) | [(17.1) d](/filings/0001437749-26-029981.md) |
| Capital expenditure | $m | [0.3 d](/filings/0001437749-24-037110.md) | [0.4 d](/filings/0001437749-26-011602.md) | [0.2](/filings/0001437749-25-019846.md) | [0.2 d](/filings/0001437749-25-028680.md) | [0.4 d](/filings/0001437749-25-037393.md) | [0.8 d](/filings/0001437749-26-011602.md) | [0.5](/filings/0001437749-26-019986.md) | [0.6 d](/filings/0001437749-26-029981.md) | [0.5 d](/filings/0001437749-25-037393.md) | [0.2 d](/filings/0001437749-26-011602.md) | [0.4](/filings/0001437749-26-019986.md) | [0.3 d](/filings/0001437749-26-029981.md) |
| Share repurchases | $m | [0.0 d](/filings/0001437749-24-037110.md) | [0.0 d](/filings/0001437749-26-011602.md) | [0.0](/filings/0001437749-24-019820.md) | [0.0 d](/filings/0001437749-24-028757.md) | [0.0 d](/filings/0001437749-24-037110.md) | [0.0 d](/filings/0001437749-26-011602.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | period not labelled (2020-07-31) | period not labelled (2021-04-30) | Q3 FY2023 (2021-10-31) | Q4 FY2023 (2022-01-31) | Q1 FY2023 (2022-04-30) | Q2 FY2023 (2022-07-31) | Q3 FY2023 (2022-10-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [0.1](/filings/0001558370-21-012489.md) | [4.0](/filings/0001558370-22-009858.md) | [133](/filings/0001558370-22-018490.md) | [0.1](/filings/0001558370-22-005527.md) | [142](/filings/0001558370-22-009858.md) | [164](/filings/0001558370-22-014290.md) | [164](/filings/0001558370-22-018490.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 9,100,444 at 2026-09-02, from the cover of the [10-Q filed 2026-09-09](/filings/0001437749-26-029981.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.